Literature DB >> 11869901

Gut intraepithelial lymphocyte development.

Delphine Guy-Grand1, Pierre Vassalli.   

Abstract

CD8alphabeta(+) and CD4(+) intraepithelial lymphocytes, the progeny of double-positive thymocytes, are oligoclonal T-cell populations that have accumulated in the gut wall as the result of repeated antigenic stimulations, which lead to rounds of traffic through the lymph/blood circuit ending in an alpha4beta7-integrin-driven homing all along the gut mucosa. In contrast, CD8alphaalpha(+) intraepithelial lymphocytes, which may be TCRgammadelta(+) or alphabeta(+), result in part from local differentiation in the gut, but studies comparing euthymic and athymic mice suggest a thymic double-negative origin for many of them.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11869901     DOI: 10.1016/s0952-7915(02)00330-8

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  11 in total

1.  Intestinal TSH production is localized in crypt enterocytes and in villus 'hotblocks' and is coupled to IL-7 production: evidence for involvement of TSH during acute enteric virus infection.

Authors:  Virginia L Scofield; Dina Montufar-Solis; Elly Cheng; Mary K Estes; John R Klein
Journal:  Immunol Lett       Date:  2005-01-07       Impact factor: 3.685

2.  Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.

Authors:  Yi-Bin Chen; Haesook T Kim; Sean McDonough; Robert D Odze; Xiaopan Yao; Suzan Lazo-Kallanian; Thomas R Spitzer; Robert Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Biol Blood Marrow Transplant       Date:  2009-07-08       Impact factor: 5.742

Review 3.  Colon cancer and the immune system: the role of tumor invading T cells.

Authors:  Maximilian Waldner; Carl-C Schimanski; Markus-F Neurath
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

Review 4.  Human intraepithelial lymphocytes.

Authors:  Toufic Mayassi; Bana Jabri
Journal:  Mucosal Immunol       Date:  2018-04-20       Impact factor: 7.313

5.  The same genomic region conditions clonal deletion and clonal deviation to the CD8alphaalpha and regulatory T cell lineages in NOD versus C57BL/6 mice.

Authors:  Phillip D Holler; Tetsuya Yamagata; Wenyu Jiang; Markus Feuerer; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

6.  Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection.

Authors:  Barbara L Shacklett; Catherine A Cox; Johan K Sandberg; Neil H Stollman; Mark A Jacobson; Douglas F Nixon
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  Bcl-2 Is Necessary to Counteract Bim and Promote Survival of TCRαβ+CD8αα+ Intraepithelial Lymphocyte Precursors in the Thymus.

Authors:  Sharmila Shanmuganad; Sarah A Hummel; Vivian Varghese; David A Hildeman
Journal:  J Immunol       Date:  2022-01-07       Impact factor: 5.422

Review 8.  Decimated or missing in action: CD4+ T cells as targets and effectors in the pathogenesis of primary HIV infection.

Authors:  Anthony D Kelleher; John J Zaunders
Journal:  Curr HIV/AIDS Rep       Date:  2006-02       Impact factor: 5.071

9.  Extrathymic T cell lymphopoiesis: ontogeny and contribution to gut intraepithelial lymphocytes in athymic and euthymic mice.

Authors:  Delphine Guy-Grand; Orly Azogui; Susanna Celli; Sylvie Darche; Michel C Nussenzweig; Philippe Kourilsky; Pierre Vassalli
Journal:  J Exp Med       Date:  2003-02-03       Impact factor: 14.307

10.  Dominant Negative FADD/MORT1 Inhibits the Development of Intestinal Intraepithelial Lymphocytes With a Marked Defect on CD8αα+TCRγδ+ T Cells.

Authors:  Xuerui Zhang; Lina Huo; Lulu Song; Zhaoqing Hu; Xinran Wang; Yuheng Han; Ying Wang; Peipei Xu; Jing Zhang; Zi-Chun Hua
Journal:  Front Immunol       Date:  2018-09-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.